Clinic
Nicholas H. Noyes Memorial Hospital
Nicholas H. Noyes Memorial Hospital was paid $16.63M by Medicaid between Jan 2018 and Dec 2024, across 241 billing codes. Its largest line is 90834, psychotherapy session, about 45 minutes — 23% of everything it billed.
33Billing provider infoNICHOLAS H. NOYES MEMORIAL HOSPITAL
DANSVILLE, NY 14437
DANSVILLE, NY 14437
33aNPI1982625661assigned 07/21/2006
28Total paid$16.63M
24GClaims366,196
24DCodes billed241
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Mental Health Clinic/Center (Including Community Mental Health Center) providers in New York
Rank by total paid#11 of 112
Median peer was paid$1.84M
This provider vs. median9.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,590 | $103K | |
| 2019 | 24,229 | $1.10M | |
| 2020 | 70,947 | $2.91M | |
| 2021 | 85,787 | $3.68M | |
| 2022 | 64,691 | $3.00M | |
| 2023 | 67,942 | $3.39M | |
| 2024incomplete | 51,010 | $2.46M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 23% | 31,645 | 22,703 | $3.75M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 12% | 23,563 | 22,632 | $1.93M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 6.1% | 11,463 | 10,095 | $1.01M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 5.8% | 8,351 | 7,025 | $957K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 4.7% | 8,706 | 7,480 | $784K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4.5% | 11,340 | 10,947 | $749K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 3.7% | 7,662 | 7,005 | $622K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.0% | 6,253 | 6,060 | $501K |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | 2.5% | 2,665 | 2,399 | $413K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.3% | 3,737 | 3,354 | $383K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.3% | 2,216 | 2,062 | $382K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.2% | 1,597 | 1,571 | $358K |
229 more codes
| 96361 | Intravenous infusion, hydration; each additional hour | 2.1% | 1,830 | $343K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.0% | 8,317 | $341K |
| 80053 | Comprehensive metabolic panel | 1.6% | 20,305 | $271K |
| 90837 | Psychotherapy session, about an hour | 1.5% | 2,041 | $257K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.1% | 782 | $186K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 7,263 | $148K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 1,325 | $137K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 719 | $119K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 180 | $119K |
| H2011 | Crisis intervention service, per 15 minutes | <1% | 694 | $98K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 259 | $97K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 682 | $94K |
| 97161 | <1% | 1,283 | $93K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 8,340 | $89K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,941 | $86K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,032 | $85K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,691 | $79K |
| 80061 | Lipid panel | <1% | 7,885 | $78K |
| 87631 | <1% | 1,449 | $75K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 21,540 | $66K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,621 | $65K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 17,993 | $60K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,266 | $59K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 802 | $53K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 578 | $52K |
| 84439 | <1% | 6,332 | $51K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,040 | $49K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,270 | $48K |
| 87081 | <1% | 5,776 | $48K | |
| 76770 | <1% | 437 | $46K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 208 | $44K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 2,655 | $44K |
| 86900 | <1% | 1,040 | $40K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 175 | $35K |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 175 | $34K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 763 | $33K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,206 | $33K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,228 | $32K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 200 | $32K |
| S5161 | Emergency response system; service fee, per month (excludes installation and testing) | <1% | 993 | $29K |
| 20610 | <1% | 572 | $29K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 480 | $29K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 105 | $27K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,572 | $27K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 1,331 | $26K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 932 | $24K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 357 | $23K |
| 72110 | <1% | 446 | $22K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,090 | $22K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 2,874 | $22K |
| 82607 | <1% | 1,908 | $21K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 129 | $21K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 545 | $21K |
| 73630 | <1% | 1,099 | $21K | |
| 73562 | <1% | 858 | $20K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,035 | $18K |
| 76830 | Ultrasound, transvaginal | <1% | 296 | $17K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 59 | $17K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,471 | $16K |
| 82728 | <1% | 1,552 | $16K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 261 | $16K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 26 | $16K |
| 90836 | <1% | 194 | $15K | |
| 73030 | <1% | 696 | $15K | |
| 81025 | <1% | 2,167 | $14K | |
| 73610 | <1% | 797 | $14K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 274 | $14K |
| 80076 | <1% | 1,526 | $13K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 55 | $13K |
| 86850 | <1% | 1,010 | $12K | |
| 73130 | <1% | 543 | $12K | |
| 73110 | <1% | 451 | $11K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 84 | $11K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,670 | $11K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,459 | $11K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,090 | $11K |
| 83735 | <1% | 3,835 | $10K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 92 | $10K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 13 | $10K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 558 | $10K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 48 | $10K |
| J2704 | Injection, propofol, 10 mg | <1% | 2,316 | $9K |
| 93971 | <1% | 130 | $9K | |
| 83550 | <1% | 1,255 | $8K | |
| 72100 | <1% | 367 | $8K | |
| 87088 | <1% | 1,386 | $8K | |
| 83540 | <1% | 1,657 | $8K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 25 | $8K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 12 | $8K |
| 86901 | <1% | 1,048 | $8K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 592 | $7K |
| 87400 | <1% | 593 | $7K | |
| 87070 | <1% | 943 | $7K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 247 | $7K |
| 85027 | <1% | 2,008 | $6K | |
| 86803 | <1% | 857 | $6K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 12 | $6K |
| 86780 | <1% | 576 | $6K | |
| 83655 | <1% | 708 | $6K | |
| 87186 | <1% | 1,085 | $6K | |
| 87158 | <1% | 1,331 | $6K | |
| 81003 | <1% | 3,275 | $6K | |
| 71271 | <1% | 121 | $6K | |
| 83721 | <1% | 699 | $5K | |
| 86140 | <1% | 1,692 | $5K | |
| 87077 | <1% | 697 | $5K | |
| 76536 | <1% | 100 | $5K | |
| V2632 | Posterior chamber intraocular lens | <1% | 266 | $5K |
| 81001 | <1% | 2,416 | $5K | |
| 84702 | <1% | 477 | $5K | |
| 76000 | <1% | 334 | $4K | |
| 84403 | <1% | 185 | $4K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 311 | $4K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 39 | $4K |
| 87634 | <1% | 122 | $4K | |
| 87340 | <1% | 680 | $4K | |
| 83690 | <1% | 2,008 | $4K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 61 | $3K |
| 72020 | <1% | 204 | $3K | |
| 86618 | <1% | 269 | $3K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,706 | $3K |
| 74018 | <1% | 160 | $3K | |
| 86703 | <1% | 214 | $3K | |
| 76801 | <1% | 53 | $3K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 12 | $3K |
| 87430 | <1% | 1,284 | $3K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 537 | $3K |
| 86592 | <1% | 707 | $3K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 113 | $3K |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | <1% | 183 | $3K |
| 84484 | <1% | 1,244 | $3K | |
| C1751 | Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) | <1% | 1,173 | $3K |
| 82746 | <1% | 246 | $3K | |
| 84153 | <1% | 144 | $3K | |
| 73502 | <1% | 144 | $3K | |
| 83880 | <1% | 89 | $3K | |
| 11721 | <1% | 119 | $2K | |
| 85610 | <1% | 953 | $2K | |
| 72050 | <1% | 53 | $2K | |
| 93975 | <1% | 13 | $2K | |
| 12001 | <1% | 12 | $2K | |
| 85651 | <1% | 928 | $2K | |
| 86941 | <1% | 454 | $2K | |
| 99404 | <1% | 24 | $2K | |
| 86038 | <1% | 265 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,542 | $2K |
| G0378 | Hospital observation service, per hour | <1% | 38 | $2K |
| 83516 | <1% | 177 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,846 | $2K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,281 | $2K |
| 59025 | Fetal non-stress test | <1% | 18 | $2K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,313 | $2K |
| 85652 | <1% | 1,061 | $2K | |
| G0432 | Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening | <1% | 112 | $2K |
| 87505 | <1% | 13 | $1K | |
| 82948 | <1% | 479 | $1K | |
| 84703 | <1% | 761 | $1K | |
| 81002 | <1% | 366 | $1K | |
| 71250 | <1% | 12 | $1K | |
| 86756 | <1% | 101 | $1K | |
| 82784 | <1% | 138 | $1K | |
| 86762 | <1% | 184 | $1K | |
| 72072 | <1% | 39 | $1K | |
| 0012A | <1% | 57 | $1K | |
| 94010 | <1% | 117 | $1K | |
| 90715 | <1% | 83 | $1K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 25 | $1K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 69 | $1K |
| 73140 | <1% | 38 | $985.39 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 273 | $892.77 |
| 0011A | <1% | 61 | $842.16 | |
| Q9956 | Injection, octafluoropropane microspheres, per ml | <1% | 43 | $719.60 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 12 | $704.20 |
| 73564 | <1% | 12 | $682.88 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 51 | $656.65 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 237 | $609.67 |
| 86430 | <1% | 144 | $607.54 | |
| 83001 | <1% | 42 | $586.51 | |
| 82150 | <1% | 178 | $580.30 | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 58 | $572.15 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 63 | $509.28 |
| 85007 | <1% | 330 | $467.29 | |
| 82565 | <1% | 205 | $440.03 | |
| 87205 | <1% | 161 | $431.61 | |
| 72070 | <1% | 12 | $409.94 | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 806 | $383.40 |
| 84480 | <1% | 40 | $351.36 | |
| 73560 | <1% | 25 | $333.55 | |
| A9576 | Injection, gadoteridol, (prohance multipack), per ml | <1% | 25 | $319.67 |
| 82950 | <1% | 80 | $308.31 | |
| 88142 | <1% | 12 | $307.74 | |
| 85730 | <1% | 195 | $282.74 | |
| 84402 | <1% | 12 | $277.16 | |
| 86364 | <1% | 36 | $272.52 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,248 | $259.09 |
| A9573 | Injection, gadopiclenol, 1 ml | <1% | 21 | $255.63 |
| 87147 | <1% | 90 | $245.79 | |
| 82570 | <1% | 65 | $233.68 | |
| 94727 | <1% | 25 | $222.83 | |
| 84520 | <1% | 149 | $222.04 | |
| 84146 | <1% | 13 | $208.38 | |
| 84460 | <1% | 87 | $162.52 | |
| 87040 | <1% | 82 | $162.20 | |
| 82043 | <1% | 12 | $143.48 | |
| 84550 | <1% | 40 | $137.69 | |
| 84100 | <1% | 47 | $132.94 | |
| Q3014 | Telehealth originating site facility fee | <1% | 14 | $117.24 |
| 82247 | <1% | 54 | $102.27 | |
| 85014 | <1% | 55 | $99.74 | |
| 86706 | <1% | 17 | $98.20 | |
| 76870 | <1% | 14 | $96.35 | |
| 86704 | <1% | 14 | $85.00 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 19 | $77.18 |
| 94729 | <1% | 12 | $75.01 | |
| 81015 | <1% | 943 | $65.33 | |
| 96376 | <1% | 95 | $62.16 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 94 | $59.82 |
| 82550 | <1% | 16 | $52.06 | |
| 85379 | <1% | 52 | $38.55 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 246 | $33.25 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 57 | $31.52 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 28 | $30.15 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 27 | $18.21 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 72 | $13.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 29 | $10.77 |
| 83605 | <1% | 27 | $9.30 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 350 | $4.30 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 73 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPRUNOSKE, MARK (CFO)
| Provider | Location | Paid |
|---|---|---|
| Nicholas H. Noyes Memorial Hospital | Geneseo, NY | $58K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.